usace.army.mil1d
The Defensive Lynchpin: Unveiling Vital Role of Class IV Combat Configured Loads in Large-Scale Combat Operations
As the sun sets over the Central Corridor, following a long day of combined arms breaching, a common story and phrase is ...
JD Supra8h
DOJ and CISA Issue Proposed Rules Regulating Export of Bulk Sensitive Data
The Department of Justice (DOJ) released a Final Rule restricting certain transfers of Americans’ sensitive personal data to identified countries ...
Nieman Journalism Lab3d
If you ask New York Times reporters to spend less time on Twitter, will they? (Spoiler: yes)
An analysis of more than 185,000 tweets by New York Times staffers showed they got less opinionated — and less frequent ...
Tax Guru5d
Bombay HC Quashes Income Tax Order for Denial of Personal Hearing without Valid Reasons
Bombay High Court quashed an income tax assessment order against Pico Capital Private Limited due to a violation of natural justice. The petitioner had explicitly requested a personal hearing during ...
Don’t sleep on Google Gemini’s Deep Research mode: 8 examples of informative reports
Use Gemini Deep Research to produce industry reports or ask it to identify new opportunities or helpful insights to grow your business.
I tested Gemini 2.0 vs Perplexity with 7 prompts created by DeepSeek — here's the winner
DeepSeek’s verdict: “Perplexity's response is the stronger of the two. While both answers are highly creative and detailed, ...
CNET on MSN5d
DeepSeek R1 First Impressions: I've Seen How the Machine Thinks
After a week of using DeepSeek's R1 reasoning model, I'm highly impressed, even if some questions are off-limits.
NIH Funding Cuts Appear to Draw on Heritage Foundation Report That Blasts ‘DEI Staff’
In its notice outlining the large cut in university funding, the US National Institutes of Health seems to draw on a report ...
Where I'd Put $10,000 Right Now - My Best Dividend Picks For Income And Growth
If I were investing $10,000 today, I would focus on undervalued essentials, GARP stocks, and opportunities tied to broader ...
Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...
Business and Financial Times on MSN4d
Mourn, Baby, Mourn! (On Trump’s Allegation of ‘Rape’ And Africa’s Fatalism)
EMPIRICAL Trump is back And naturally, so is his lsquo;the United States of America is a victim of international trade rsquo; ...
JD Supra4d
FDA Finalizes Guidance on Scientific Information on Unapproved Uses (SIUU) Communications
FDA published a final version of its guidance document, “Communications From Firms to Health Care Providers Regarding ...